NCT02141555View on ClinicalTrials.gov

Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2016

Conditions
Spontaneous Abortion in First Trimester
Interventions
DRUG

Vaginal Misoprostol

Misoprostol inserted into vagina

DRUG

Buccal Misoprostol

Misoprostol placed between the gum and cheek and allowed to dissolve for 30 minutes with the remnants swallowed after this time.

Trial Locations (2)

92037

Universty of California San Diego Perlman Clinic, La Jolla

92103

University of California San Diego Medical Offices South Clinic, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02141555 - Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss | Biotech Hunter | Biotech Hunter